12-55637042-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_206899.1(OR10P1):c.151G>T(p.Val51Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V51I) has been classified as Uncertain significance.
Frequency
Consequence
NM_206899.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10P1 | ENST00000309675.3 | c.151G>T | p.Val51Phe | missense_variant | Exon 1 of 1 | 6 | NM_206899.1 | ENSP00000308082.2 | ||
ENSG00000258763 | ENST00000715996.1 | n.493+1872C>A | intron_variant | Intron 2 of 6 | ||||||
ENSG00000258763 | ENST00000804081.1 | n.231+352C>A | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151954Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151954Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74222 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.151G>T (p.V51F) alteration is located in exon 1 (coding exon 1) of the OR10P1 gene. This alteration results from a G to T substitution at nucleotide position 151, causing the valine (V) at amino acid position 51 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at